Your email has been successfully added to our mailing list.

×
0.00158353127474264 -0.00237529691211396 -0.00950118764845614 -0.0419635787806809 -0.0205859065716548 -0.0451306413301663 -0.0498812351543944 -0.0506730007917657
Stock impact report

UroGen Pharma announces FDA acceptance of new drug application for UGN-102 [Seeking Alpha]

UroGen Pharma Ltd. - Ordinary Shares (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
Company Research Source: Seeking Alpha
UGN-102 could become the first FDA-approved medicine for the treatment of low-grade intermediate-risk non-muscle invasive bladder cancer. The FDA has assigned a Prescription Drug User Fee Act goal date of June 13, 2025. "We believe that, if approved, UGN-102's ability to achieve durable complete responses and potentially reduce recurrence rates while extending treatment-free intervals will represent a significant advance in managing LG-IR-NMIBC." said Dr. Mark Schoenberg, CMO. URGN after hours to $12.76. More on UroGen Pharma UroGen Pharma's JELMYTO And UGN-102: A Strong Buy In The Urological Cancer Sector UroGen Pharma: There Is Some Potential Here UroGen Pharma Ltd. (URGN) Q2 2024 Earnings Call Transcript UroGen started at buy by EF Hutton, RTGel technology cited UroGen Pharma misses top-line and bottom-line estimates; lowers FY24 outlook Recommended For You Comments More Trending News Recommended For You More Trending News Show less Read more
Impact Snapshot
Event Time:
URGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for URGN alerts
Opt-in for
URGN alerts

from News Quantified
Opt-in for
URGN alerts

from News Quantified